Hanall BioPharma Q3 Operating Profit Rises 265.1% Year on Year
Bitget2026/10/28 08:44- Hanall BioPharma’s third-quarter 2026 net profit rose 924.2% year over year to KRW 3.06 billion.
- Operating profit increased 265.1% from a year earlier to KRW 1.27 billion.
- Revenue fell 2.2% year over year to KRW 39.91 billion.
- Sequentially, operating profit dropped 77.2%; revenue declined 9.9%.
- Nine-month net results swung to a KRW 15.89 billion loss from a KRW 690 million profit a year earlier.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Silver Price Forecast: XAG/USD trades flat around $53 ahead of US inflation data
Swiss Franc holds ground as US Dollar consolidates ahead of CPI inflation data
Net profit surges fivefold but masks decline in core business; crypto mining companies' shift to AI poses hidden risks
Marathon Holdings' Q3 net profit reached $632 million, up 413% year-on-year. However, its mining revenue declined by 35%. The company relied on selling 13,500 BTC to pay off debts and is now betting on AI infrastructure, increasing the risk of an imbalanced profit structure.
Lithium-For-Earth Raises KRW 1.32 Billion in Private Placement
Crypto prices
More
